Understanding Duchenne Muscular Dystrophy
What is Duchenne Muscular Dystrophy?
Duchenne muscular dystrophy (DMD) is a rare and progressive disease that results in a loss of muscle strength. It is caused by a mutation in the DMD gene, which prevents the production of dystrophin, a protein essential for the structure of muscle cells. Without dystrophin, muscle cells are gradually damaged, leading to loss of mobility and severe complications.
This disease primarily affects boys and progresses more rapidly than other myopathies. It is usually diagnosed in childhood, unlike Becker muscular dystrophy.
Differences between Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Feature
Duchenne Muscular Dystrophy
Becker Muscular Dystrophy
Dystrophin
Absent or nearly absent
Present in small amounts
Feature | Duchenne Muscular Dystrophy | Becker Muscular Dystrophy | Onset | Before age 5 | Usually around age 12 |
|---|---|---|
Mobility | Loss of walking ability before age 12 | Walking preserved longer |
Dystrophin | Absent or nearly absent | Present in small amounts
|
Genetic Causes
Duchenne muscular dystrophy results from an abnormality in the DMD gene, located on the X chromosome. This gene plays a crucial role, as it enables the production of dystrophin, a protein essential for protecting and stabilizing muscles during contraction. Without dystrophin, muscles become fragile and gradually deteriorate, leading to the muscle weakness characteristic of the disease
How does this mutation occur?
Anomalies in the DMD gene may take several forms:
- Deletions: part of the gene is missing, preventing dystrophin production.
- Duplications: part of the gene is mistakenly repeated, rendering dystrophin unusable.
- Point mutations: a small change in the gene is enough to disrupt its function.
In most cases, these anomalies prevent normal dystrophin production or make it completely absent.
Affected Population
Duchenne muscular dystrophy is an X-linked genetic disorder, which explains why it primarily affects boys. It occurs in about 1 in 3,300 male births.
Boys have only one X chromosome: if a child carries the mutation, he will develop the disease. Girls have two X chromosomes: if one carries the mutation, the other can often compensate. This is why girls rarely develop the disease, although they can transmit it as carriers. In about 30% of cases, the mutation appears spontaneously, with neither parent carrying it. The disease can therefore occur even without a known family history.
Disease Progression
Duchenne muscular dystrophy usually appears between ages 2 and 4. The first signs include delayed walking and frequent falls, while muscles gradually weaken. As the disease progresses, children experience significant muscle deterioration leading to loss of mobility around age 12.
Beyond physical difficulties, Duchenne muscular dystrophy can also cause cardiac and respiratory complications.
Symptoms and Diagnosis
Early Symptoms
The early symptoms of Duchenne muscular dystrophy include:
- Delayed walking: children begin walking later than others, often after 18 months.
- Frequent falls: due to progressive muscle weakness, children stumble easily, especially when running or climbing stairs.
- Difficulty standing up from the floor: they use a specific technique called Gowers’ maneuver, pushing on their legs with their hands.
- Calf hypertrophy: calves may look muscular and firm, but in reality, muscle is replaced by fibrous and fatty tissue.
- Muscle weakness in legs and pelvis: resulting in unsteady gait and difficulty running or jumping.
Diagnostic Methods
Diagnosis of Duchenne muscular dystrophy relies on several medical examinations:
- Clinical exam and observation of symptoms: to identify signs such as Gowers’ maneuver and calf hypertrophy.
- Muscle enzyme (CPK) test: a blood test measures creatine phosphokinase (CPK), released during muscle breakdown. Very high CPK levels are an early indicator of muscle disease.
- Genetic testing: DNA analysis confirms the DMD mutation, crucial for accurate diagnosis.
- Muscle MRI: allows assessment of muscle condition and detection of disease signs, helping to distinguish DMD from other disorders.
- Muscle biopsy (rare): if genetic tests are inconclusive, a small sample may be analyzed to confirm absence of dystrophin.
Thanks to medical advances, DMD diagnosis is now faster and more accurate, allowing for early and appropriate care.
Associated Complications
In addition to muscle weakness, DMD causes several complications:
- Respiratory difficulties: weakened respiratory muscles increase the risk of lung infections, sometimes requiring respiratory support.
- Cardiac involvement: absence of dystrophin in the heart muscle can cause cardiomyopathy, requiring monitoring and treatment.
- Orthopedic deformities: loss of mobility often leads to contractures (joint stiffness) and scoliosis, sometimes requiring braces or surgery
Current Treatments and Multidisciplinary Care
There is currently no cure for Duchenne muscular dystrophy. However, several treatments can slow progression and improve quality of life: drug therapy, physiotherapy, and multidisciplinary care (neurologists, cardiologists, physiotherapists, psychologists, speech therapists, etc.).
Drug Treatments
Several treatments are used today to slow disease progression:
- Corticosteroids (prednisone, deflazacort): commonly prescribed to reduce muscle degeneration.
- Gene therapy and new approaches like CRISPR-Cas9: still in development, aiming to target the root cause of the disease.
Treatment
Objective
Status
Traitement | Objectif | Statut | Corticoïdes | Ralentir la progression | Traitement standard |
|---|---|---|
Thérapie génique | Restaurer la dystrophine | En développement |
Exon skipping | Corriger l’anomalie génétique | Essais cliniques
|
CRISPR-Cas9 | Corriger directement la mutation génétique du gène DMD | En phase de recherche |
Importance of Physiotherapy
Physiotherapy is essential and often a regular practice for individuals with Duchenne muscular dystrophy. It helps to:
- Preserve joint mobility
- Prevent contractures
- Improve posture and breathing
Ongoing Research and Innovations
Recent years have seen major advances in DMD research, opening new possibilities for treatment. The main areas are: gene therapy, CRISPR-Cas9, cell therapy, and new drugs.
Gene Therapy and Exon Skipping
Gene therapy aims to correct or replace the defective DMD gene to restore dystrophin production. Clinical trials (e.g. Exondys 51) are underway, using exon skipping to bypass mutations and produce a functional dystrophin. Though not a cure, this slows disease progression.
CRISPR-Cas9
The CRISPR-Cas9 technology precisely edits DNA and may correct DMD mutations, acting like “molecular scissors.” Still experimental, it shows encouraging results, but more research is needed before clinical use.
Cell Therapy
Cell therapy uses stem cells (capable of becoming any type of cell) to regenerate damaged muscle. Implanting stem cells that can turn into muscle cells may partially restore muscle function. Still experimental, this could complement gene therapy.
New Drugs
New drugs are in development to slow DMD progression and improve care. Some inhibit myostatin, a protein limiting muscle growth, potentially boosting muscle development in affected individuals.
Innovative Solutions for Autonomy and Quality of Life
As DMD progresses, it impacts daily life. Thanks to technology, autonomy and independence can be improved.
Home Adaptations and Assistance
There are suitable home adaptations for people living with Duchenne muscular dystrophy. These adaptations help maintain an optimal quality of life. Indeed, individuals may experience difficulties with mobility and require assistance with certain daily activities. Several types of equipment can be installed to facilitate movement and ensure a safe living environment.
- Medical beds: improve comfort and ease repositioning.
- Lifts and hoists: facilitate transfers between rooms safely.
- Home automation (domotics): allows control of lights, heating, windows, etc., improving independence. Solutions such as those from JIB are co-designed with users.
ORTHOPUS and robotic solutions for Duchenne muscular dystrophy
At ORTHOPUS, we develop a range of innovative robotic arm assistants designed to support arm mobility. These technologies assist users with everyday tasks such as eating, brushing their hair, or even adjusting their glasses. Thanks to their smart motors, these arm supports adapt to each user’s movements and specific needs, offering personalized assistance. This helps maintain a degree of autonomy and reduces dependency.
The ORTHOPUS Supporter compensates for the weight of the arm, making vertical movements easier. Customizable, it adapts to your style, works on both electric wheelchairs and tables, and memorizes the level of support that suits you.
The ORTHOPUS Partner, still in the prototyping stage, is a robotic assistant that supports all arm movements:
- Vertical movements: up and down
- Lateral movements: left and right
- Depth movements: forward and backward
With a diverse range of arm-assistance products, ORTHOPUS aims to adapt to the evolving needs of users. The goal is to ensure continuity of assistance and flexibility of equipment. Inspired by the open-source hardware community, we at ORTHOPUS have chosen to offer increased customization of our devices, so that users can truly make them their own.
Through these robotic assistance solutions, ORTHOPUS enables users to continue living life to the fullest and to preserve their autonomy in the long term. The robotic arms not only assist with daily movements, but also contribute to maintaining muscle function. They allow essential gestures to be repeated, improving both physical and psychological well-being, and reducing the feeling of lost independence.
💜 “The advantage in pediatrics compared to adults is that in children, function has not been lost for long (or not completely gone), so it is easier.” — Christophe Prudhomme, Occupational Therapist, CHU d’Estaing, Clermont-Ferrand
💜 “The ORTHOPUS Supporter has also had a positive effect on my mental health because I can be creative again more easily.” — Nina, graphic designer – illustrator, Dutch user of the ORTHOPUS Supporter
Thanks to medical progress and technological innovations, people with Duchenne muscular dystrophy now receive better care, improving comfort and independence.
Sources :
- https://www.afm-telethon.fr/fr/fiches-maladies/dystrophie-musculaire-de-duchenne
- https://www.msdmanuals.com/fr/accueil/problèmes-de-santé-infantiles/dystrophies-musculaires-et-troubles-associés/dystrophie-musculaire-de-duchenne-et-dystrophie-musculaire-de-becker
- https://www.has-sante.fr/upload/docs/application/pdf/2019-11/pnds_duchenne_raccourci_18_pages_final_nov_2019_.pdf
- https://www.inserm.fr/dossier/myopathie-duchenne/
- https://fr.wikipedia.org/w/index.php?title=Signe_de_Gowers&oldid=204310127
- http://www.orpha.net/fr/disease/detail/262
- https://www.msdmanuals.com/fr/accueil/multimedia/table/corticoïdes-utilisations-et-effets-secondaires
- https://www.afm-telethon.fr/fr/termes/therapie-genique
- https://www.afm-telethon.fr/fr/termes/crisprcas9